Ashland Expands EMEA Reach with Exclusive Cellulose Ether Distribution Deal

ASH
January 27, 2026

Ashland Inc. announced an exclusive distribution partnership with Univar Solutions B.V., a subsidiary of Univar Solutions LLC, to supply its cellulose ether derivatives and polyvinylpolypyrrolidone (PVPP) to the food and beverage industry across the EMEA region.

The agreement, effective January 1 2026, grants Univar’s Foodology by Univar Solutions business sole rights to market and distribute Ashland’s products in 18 countries. The rollout is phased: the United Kingdom, Ireland, France, Spain, Portugal, Germany, Austria, Switzerland, and Hungary begin distribution on January 1; the United Arab Emirates, Saudi Arabia, Lebanon, Kuwait, Bahrain, Jordan, and Oman start on March 1; and Turkey follows on April 1.

Strategically, the partnership expands Ashland’s distribution footprint and leverages Univar’s established sales network, positioning the company to tap growing demand for plant‑based proteins, gluten‑free bakery products, and other functional food applications. The EMEA food ingredients market is projected to grow at a 7.4% CAGR through 2030, while the cellulose ether segment is expected to expand at 6.4% CAGR to 2032—trends that the partnership directly supports.

From a business perspective, Ashland can focus on production while Univar handles distribution, giving both parties a complementary advantage. Univar gains a high‑value, low‑volume portfolio that aligns with sustainability and plant‑based consumer trends, while Ashland gains accelerated market penetration and revenue potential in a key growth region. The deal also dovetails with Ashland’s portfolio‑optimization strategy, which has concentrated resources on high‑margin specialty ingredients.

The partnership follows Ashland’s Q4 2025 earnings miss, but management highlighted strong margins and a disciplined approach to portfolio alignment. The deal signals confidence in the company’s growth prospects and supports its FY 2026 outlook of $1.835 billion to $1.905 billion in sales and $400 million to $430 million in adjusted EBITDA.

Overall, the exclusive distribution agreement represents a significant milestone that could enhance Ashland’s market penetration and revenue potential in EMEA, reinforcing its strategy to capitalize on functional ingredient trends.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.